The funding comes from the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program at ARPA-H, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results